Chinese Medicine Modernization and Big Data Research Center, Nanjing Hospital of Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Department of Pharmacology, School of Integral Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):259-270. doi: 10.1080/17474124.2020.1736042. Epub 2020 Mar 3.
: Epigenetic modification is a type of gene expression and regulation that does not involve changes in DNA sequences. An increasing number of studies have proven that epigenetic modifications play an important role in the occurrence and progression of liver diseases through the gene regulation and protein expressions of hepatocellular lipid metabolism, inflammatory reaction, cell proliferation, and activation, etc.: In this study, we elaborated and analyzed the underlying functional mechanism of epigenetic modification in alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), liver fibrosis (LF), viral hepatitis, hepatocellular carcinoma (HCC), and research progress of recent years.: The further understanding of epigenetic mechanisms that can regulate gene expression and cell phenotype leads to new insights in epigenetic control of chronic liver disease. Currently, hepatologists are exploring the role of DNA methylation, histone/chromatin modification, and non-coding RNA in specific liver pathology. These findings have led to advances in direct epigenetic biomarker testing of patient tissue or body fluid specimens, as well as quantitative analysis. Based on these findings, drug validation of some targets involved in the epigenetic mechanism of liver disease is gradually being carried out clinically.
表观遗传修饰是一种基因表达和调控的方式,不涉及 DNA 序列的变化。越来越多的研究证明,表观遗传修饰通过肝细胞脂质代谢、炎症反应、细胞增殖和活化等方面的基因调控和蛋白表达,在肝脏疾病的发生和进展中发挥重要作用:本研究详细阐述和分析了表观遗传修饰在酒精性肝病 (ALD)、非酒精性脂肪性肝病 (NAFLD)、肝纤维化 (LF)、病毒性肝炎、肝细胞癌 (HCC)中的作用机制,并对近年来的研究进展进行了分析。:对能够调节基因表达和细胞表型的表观遗传机制的进一步了解,为慢性肝病的表观遗传调控提供了新的见解。目前,肝病学家正在探索 DNA 甲基化、组蛋白/染色质修饰和非编码 RNA 在特定肝脏病理中的作用。这些发现促进了对患者组织或体液标本进行直接表观遗传生物标志物检测和定量分析。基于这些发现,一些涉及肝病表观遗传机制的靶点的药物验证正在逐步在临床上进行。